William F. Regine, MD, FACR, FASTRO, FACRO


Isadore and Fannie Schneider Foxman Chair and Professor of Radiation Oncology

University of Maryland School of Medicine

Interim President, University of Maryland Faculty Physicians, Inc.

Executive Director, Maryland Proton Treatment Center

Department of Radiation Oncology

School Affiliation

School of Medicine


  • GI and CNS Malignancies


Dr. Regine, ranked in the top five in National Institutes of Health research funding, is recognized nationally and internationally in the areas of gastrointestinal and sympathetic nervous system malignancies and in the use of stereotactic radiosurgery. At the Maryland Proton Treatment Center, he leads the first and most advanced facility of its kind in the Baltimore-Washington region, providing nearly 2,000 cancer patients a year with precise “pencil-beam” technology to treat solid tumors. UMB’s 2016 Entrepreneur of the Year, Dr. Regine has served as principal or co-principal investigator on at least four National Cancer Institute (NCI)-sponsored cooperative group clinical trials. He has also been the Radiation Oncology Principal Investigator/Study Chairman of at least 2 additional Institutional clinical trials published in JAMA and the Lancet which defined new standards of care for patients with brain metastases and malignant spinal cord compression. He is co-editor "Principles and Practices of Stereotactic Radiosurgery," the first comprehensive textbook of its kind. His department ranks top 5 in NIH funding for Radiation Oncology. Dr. Regine was named a "Top Doctor" in the specialty of Radiation Oncology by Baltimore Magazine and "Super Doctor" in Mid-Atlantic by Washington Post Magazine multiple years.

For interview requests, please contact the Office of Communications and Public Affairs.

Tagged: The Future of Health Care  

This information was last updated May 17, 2023.